1. A case of onychomadesis associated with chilblain‐like lesions after COVID‐19 infection. (28th May 2022) Authors: Colonna, C.; Giacalone, S.; Zussino, M.; Monzani, N.A.; Cambiaghi, S.; Cavalli, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 9(2022) Page Start: e668 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A single‐centre real‐life experience on effectiveness and safety of dupilumab in adolescents with severe atopic dermatitis in treatment with cyclosporine A. (1st May 2021) Authors: Colonna, C.; Zussino, M.; Ponziani, A.; Gelmetti, C.; Monzani, N.A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 8(2021) Page Start: e533 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Treatment of children from 6 to 11 years old affected by moderate–severe atopic dermatitis with dupilumab: a first perspective from a single‐center real‐life experience in Italy. (3rd February 2022) Authors: Colonna, C.; Zussino, M.; Monzani, N.A.; Ponziani, A.; Cavalli, R. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 6(2022) Page Start: e478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗